NM_152393.4:c.395A>G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_152393.4(KLHL40):c.395A>G(p.Asn132Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,610,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_152393.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151846Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247652Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134514
GnomAD4 exome AF: 0.00000686 AC: 10AN: 1458400Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 725718
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151846Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74164
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.395A>G (p.N132S) alteration is located in exon 1 (coding exon 1) of the KLHL40 gene. This alteration results from a A to G substitution at nucleotide position 395, causing the asparagine (N) at amino acid position 132 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Nemaline myopathy 8 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs767039942, ExAC 0.006%). This variant has not been reported in the literature in individuals with KLHL40-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This sequence change replaces asparagine with serine at codon 132 of the KLHL40 protein (p.Asn132Ser). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and serine. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at